secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2025-07-31T23:59:59+00:00
Accession:  0001472375-25-000083
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma enters licensing deal with Holista for ovine collagen wound care
--------------------------------------------------------------------------------

- Exclusive rights to use Holista's ovine collagen in wound care and distribution in USA.
- Ovine nano-collagen integrated into Regenerex's QBx™ technology to accelerate deep tissue regeneration.
- Collagen sourced from ethically raised, disease-free Australian sheep; avoids mad cow disease concerns.
- CEO Greg Pilant says ovine collagen is safer and more culturally acceptable than bovine/porcine sources.
- Agreement targets advanced wound care solutions for U.S. and international markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237525000083/0001472375-25-000083-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237525000083/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-25-000083

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer